PharmacyCodes



Norditropin (Novo Nordisk) en es it fr

Norditropin (Novo Nordisk) Brand names, Norditropin (Novo Nordisk) Analogs

Norditropin (Novo Nordisk) Brand Names Mixture

  • No information avaliable

Norditropin (Novo Nordisk) Chemical_Formula

C990H1532N262O300S7

Norditropin (Novo Nordisk) RX_link

http://www.rxlist.com/cgi/generic3/nutropin.htm

Norditropin (Novo Nordisk) fda sheet

Norditropin (Novo Nordisk) msds (material safety sheet)

Norditropin (Novo Nordisk) Synthesis Reference

No information avaliable

Norditropin (Novo Nordisk) Molecular Weight

22129.0

Norditropin (Novo Nordisk) Melting Point

76 oC at pH 3.5 (Gomez-Orellana, I. et al., Protein Sci. 7:1352-1358 (1998).

Norditropin (Novo Nordisk) H2O Solubility

No information avaliable

Norditropin (Novo Nordisk) State

Liquid

Norditropin (Novo Nordisk) LogP

-0.411

Norditropin (Novo Nordisk) Dosage Forms

Solution (Subcutaneous Injection); Powder for solution

Norditropin (Novo Nordisk) Indication

For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss

Norditropin (Novo Nordisk) Pharmacology

Used in the treatment of dwarfism and growth failure, growth hormone (hGH) stimulates skeletal growth in pediatric patients with growth failure due to a lack of adequate secretion of endogenous GH. Skeletal growth is accomplished at the epiphyseal plates at the ends of a growing bone. Growth and metabolism of epiphyseal plate cells are directly stimulated by GH and one of its mediators, IGF-I (insulin-like growth factor).

Norditropin (Novo Nordisk) Absorption

No information avaliable

Norditropin (Novo Nordisk) side effects and Toxicity

No information avaliable

Norditropin (Novo Nordisk) Patient Information

BIOD00086.html

Norditropin (Novo Nordisk) Organisms Affected

Humans and other mammals